News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Edgeline Holdings Announces the Acquisition of Intertech Bio Has Been Completed



12/4/2007 11:06:06 AM

HOUSTON--(BUSINESS WIRE)--Edgeline Holdings, Inc. (OTCBB:ELHI) announced today that it has completed the acquisition of Intertech Bio Corporation. Intertech Bio currently focuses on developing novel cancer treatments specifically targeting the brain, pancreatic and ovarian tumors. Intertech Bio will be moving to offices near the Texas Medical Center in Houston, Texas which is home to some of the most premier cancer treatment centers in the world.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES